Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Abraham

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotorsTing Tao, Hui Shi, Luca Mariani, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Genetic Predisposition to Neuroblastoma Results from a Regulatory Polymorphism that Promotes the Adrenergic Cell StateNina Weichert-Leahey, Hui Shi, Ting Tao, et al.
The Journal of Clinical Investigation|May 15, 2023
Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell stateNina Weichert-Leahey, Hui Shi, Ting Tao, et al.
Cell|November 24, 2014
CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancerEdmond Chipumuro, Eugenio Marco, Camilla L Christensen, et al.
Cell|September 26, 2015
CDK7-dependent transcriptional addiction in triple-negative breast cancerYubao Wang, Tinghu Zhang, Nicholas Kwiatkowski, et al.
Nature Communications|June 2, 2017
Corrigendum: Small genomic insertions form enhancers that misregulate oncogenesBrian J Abraham, Denes Hnisz, Abraham S Weintraub, et al.
Cancer Cell|January 24, 2018
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing SarcomaAmanda Balboni Iniguez, Björn Stolte, Emily Jue Wang, et al.
Nature Communications|December 11, 2019
ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitryLu Wang, Tze King Tan, Adam D Durbin, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Multitargeted Reduction of Inflammation and Atherosclerosis in <i>Tet2</i> -deficient CHIP via XPO1 Inhibition and Atf3 restorationNicole Prutsch, Amélie Vromman, Brittaney Leeper, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
KAT6A/B inhibition synergizes with retinoic acid and enhances the efficacy of GD2-targeted immunotherapy in neuroblastomaNina Weichert-Leahey, Alla Berezovskaya, Mark W Zimmerman, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotorsTing Tao, Hui Shi, Luca Mariani, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Genetic Predisposition to Neuroblastoma Results from a Regulatory Polymorphism that Promotes the Adrenergic Cell StateNina Weichert-Leahey, Hui Shi, Ting Tao, et al.
The Journal of Clinical Investigation|May 15, 2023
Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell stateNina Weichert-Leahey, Hui Shi, Ting Tao, et al.
Cell|November 24, 2014
CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancerEdmond Chipumuro, Eugenio Marco, Camilla L Christensen, et al.
Cell|September 26, 2015
CDK7-dependent transcriptional addiction in triple-negative breast cancerYubao Wang, Tinghu Zhang, Nicholas Kwiatkowski, et al.
Nature Communications|June 2, 2017
Corrigendum: Small genomic insertions form enhancers that misregulate oncogenesBrian J Abraham, Denes Hnisz, Abraham S Weintraub, et al.
Cancer Cell|January 24, 2018
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing SarcomaAmanda Balboni Iniguez, Björn Stolte, Emily Jue Wang, et al.
Nature Communications|December 11, 2019
ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitryLu Wang, Tze King Tan, Adam D Durbin, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Multitargeted Reduction of Inflammation and Atherosclerosis in <i>Tet2</i> -deficient CHIP via XPO1 Inhibition and Atf3 restorationNicole Prutsch, Amélie Vromman, Brittaney Leeper, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
KAT6A/B inhibition synergizes with retinoic acid and enhances the efficacy of GD2-targeted immunotherapy in neuroblastomaNina Weichert-Leahey, Alla Berezovskaya, Mark W Zimmerman, et al.
Pageof 8